Back to RAD
Rite Aid Reports 2.9 Percent Same Store Sales Increase for April

Rite Aid Corporation (NYSE: RAD) today announced sales results for April.

Monthly Sales

For the four weeks ended April 28, 2012, same store sales increased 2.9 percent over the prior-year period. April front-end same store sales increased 2.7 percent. Pharmacy same store sales, which included an approximate 311 basis points negative impact from new generic introductions increased 3.0 percent. Prescription count at comparable stores increased 3.8 percent over the prior-year period.

Total drugstore sales for the four-week period increased 2.5 percent to $1.993 billion compared to $1.945 billion for the same period last year. Prescription sales accounted for 67.9 percent of drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.

Year-to-Date Sales

Same store sales for the eight-week period ended April 28, 2012 increased 3.3 percent, consisting of a 3.6 percent front-end same store sales increase and a 3.1 percent increase in pharmacy same store sales. Prescriptions filled at comparable stores increased 3.2 percent over the prior-year period.

Total drugstore sales for the eight weeks ended April 28, 2012 increased 2.8 percent to $3.982 billion from $3.875 billion in last year’s like period. Prescription sales accounted for 68.5 percent of total drugstore sales, and third party prescription sales represented 96.7 percent of pharmacy sales.

Rite Aid is one of the nation’s largest drugstore chains. On April 28, 2012, the company operated 4,658 stores compared to 4,705 stores in the like period a year ago. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at http://www.riteaid.com. Note that all sales data in this release is preliminary, unaudited and subject to revision.

Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties that are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Rite Aid expressly disclaims any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

(c) 2014 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
Back to RAD
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki